(Q47377608)

15 January 2018

title

Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer (English)

1 reference

15 January 2018

1 reference

2

Alan W Partin

1 reference

15 January 2018

5

Patrick C Walsh

1 reference

15 January 2018

Leslie Mangold

series ordinal

3

object named as

Leslie A Mangold

1 reference

15 January 2018

Jonathan I. Epstein

series ordinal

4

object named as

Jonathan I Epstein

1 reference

15 January 2018

author name string

Masood A Khan

series ordinal

1

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 November 2003

1 reference

15 January 2018

published in

Urology

1 reference

15 January 2018

volume

62

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

866-871

1 reference

15 January 2018

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Disease progression following radical prostatectomy in men with Gleason score 7 tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

Management of high-risk populations with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900674-5

7 January 2021

10.1016/S0090-4295(03)00674-5

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018